Global Pulmonary Embolism Therapeutics Market 2019-2023
|出版商||TechNavio (Infiniti Research Ltd.)||商品編碼||843040|
|出版日期||內容資訊||英文 119 Pages
|肺動脈栓塞治療藥的全球市場 2019年∼2023年 Global Pulmonary Embolism Therapeutics Market 2019-2023|
|出版日期: 2019年05月06日||內容資訊: 英文 119 Pages||
The increasing awareness programs and campaigns are expected to trigger the pulmonary embolism therapeutics market growth during the forecast period. The increasing awareness campaigns will improve the awareness of the severity of blood clots, resulting in various patients undergoing diagnosis and treatment on time. Such growing popularity will eventually boost the market growth in the forthcoming years. Technavio's analysts have predicted that the pulmonary embolism therapeutics market will register a CAGR of 9% by 2023.
Traditionally, the global pulmonary embolism therapeutics market was dominated by Heparin, an anticoagulant drug, which is administered through parenteral route. The market also had various other anticoagulant drugs that were approved; however, most of these drugs were administered through invasive routes. These drugs require no or very less patient monitoring unlike their predecessors from the parenteral route. This will further aid to the popularity of oral anticoagulants.
The increasing popularity and the advances in alternative treatment methods are expected to pose a major challenge to the growth of the global pulmonary embolism therapeutics market during the forecast period.
For the detailed list of factors that will drive and challenge the growth of the pulmonary embolism therapeutics market during 2019-2023, view our report.
The market appears to be highly concentrated and with the presence of a few market players. Several vendors in the market are also entering into strategic alliances to manufacture the drugs so that they could concentrate on their core competencies such as research. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.